Oxford Centre for Diabetes, Endocrinology and Metabolism
OCDEM is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases. By promoting world-class research, we aim to enhance understanding of these diseases and to accelerate the search for new treatments and cures.
Head of OCDEM
Latest Publications
The Relation Between Adult Weight Gain, Adipocyte Volume And The Metabolic Profile At Middle Age
Verkouter I. et al, (2021), The Journal of Clinical Endocrinology & Metabolism
Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D.
Viñuela A. et al, (2020), Nat Commun, 11
Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells.
Haythorne E. et al, (2019), Nat Commun, 10
Whole genome sequence analysis identifies a PAX2 mutation to establish a correct diagnosis for a syndromic form of hyperuricemia.
Stevenson M. et al, (2020), Am J Med Genet A
Donor insulin use predicts beta-cell function after islet transplantation.
Shapey IM. et al, (2020), Diabetes Obes Metab
Latest News
PTH infused insulin pump used as an alternative treatment for young patients with ADH1
13 July 2021
Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.
Early blood-sugar levels in type 2 diabetes crucial for future prognosis
12 July 2021
People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.
Researchers develop cheap, quick COVID-19 antibody test
29 March 2021
OCDEM Vacancies
Events
View previous and upcoming events in OCDEM.